Formulation and in-vitro characterization of floating sustained-release tablets of metformin hydrochloride
Metformin HCl, a drug from biguanide class, is the most commonly used first-line antihyperglycemic agent in the treatment of NIDDM [1]. The major problems associated with the drug are high dose (1.5-2.0 g/day), frequent dosing due to its shorter biological half-life (1.5-4.9 hr), and low bioavailabi...
| Main Authors: | , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/38281/ http://irep.iium.edu.my/38281/ http://irep.iium.edu.my/38281/1/metformin.pdf http://irep.iium.edu.my/38281/2/Binder1.pdf |